Bitcoin posted its biggest two-day retreat over the weekend since the US election amid a bout of caution in global markets as ...

A two-month slump has all but wiped out the US Treasury market’s gains for the year, as traders brace for Donald Trump’s ...

If Wall Street learned one thing during Donald Trump’s first term as president, it’s that the stock market is a way he keeps ...

We recently made a list of UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors. In this piece, ...

Investors who have been rewarded for their bets on Argentine President Javier Milei are doubling down on the country's stocks ...

Global funds net sold Rs 4,960 crore of Fully Accessible Route debt last week, which is the biggest weekly outflow since they ...

Wall St. Insights Jamie Dimon, CEO of JPMorgan Chase, uses his experience to help others succeed in their careers. Many ...

British Prime Minister Keir Starmer is set to hold discussions with Chinese President Xi Jinping and advocate for increased ...

Samsung shares surge on a $7.2 billion buyback plan. Analysts view it as a catalyst for growth, supporting stock amid AI ...

The repurchase plan comes amid an ongoing drive by South Korea’s government and market regulators to boost the low valuations ...

GSA Capital Partners LLP lifted its stake in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 66.2% during the 3rd quarter, HoldingsChannel reports. The firm owned 24,634 shares of the ...